According to Nautilus Biotechnology's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -A$0.12 Billion | 11.16% |
2023 | -A$0.11 Billion | 9.93% |
2022 | -A$93.37 Million | 15.12% |
2021 | -A$81.1 Million |